Covid19: Pfizer and BioNTech Strike a Deal, 100 Million Vaccines to Be Produced in SA

Covid19: Pfizer and BioNTech Strike a Deal, 100 Million Vaccines to Be Produced in SA

  • Two of the largest vaccine companies have signed a deal with South African company Biovac to manufacture vaccines
  • Biovac will now manufacture vaccines at the facility in Cape Town, a first for the African continent
  • Biovac is expected to produce 100 million vaccines that will be distributed to 55 countries under the African Union

PAY ATTENTION: Click “See First” under the “Following” tab to see Briefly.co.za News on your News Feed!

BioNTech and Pfizer, two of the world's largest vaccine companies, said on Wednesday that they had secured a South African partner to manufacture the Covid-19 vaccine locally. This agreement makes it the first of its kind on the African continent.

Biovac Institute will manufacture the Covid-19 vaccine at their plant in Cape Town, according to Fin24.

Pfizer, BioNTech, Biovac, Manufacture, Cape Town, Vaccine Deal, 100 Million Vaccines, Produced in South Africa
South African company Biovac has signed a contract with BioTech and Pfizer to manufacture Covid-19 vaccines locally. Image: Mujahid Safodien/AFP
Source: Getty Images

Biovac previously collaborated with Pfizer on the Prevnar 13 vaccine and will manufacture and distribute vaccines to Pfizer and BioNTech's global supply chain.

Read also

Peaceful anti vax protest turns into squabble with police, 2 arrested: "Plague rats"

PAY ATTENTION: Never miss breaking news – join Briefly News' Telegram channel

Getting the project off the ground would take time with the first African manufactured vaccines not being expected until 2022, according to eNCA. Biovac is expected to produce more than 100 million doses per year once it is up and operating. The vaccines will be distributed to 55 countries under the African Union.

Biovac chief executive officer Morena Makhoana stated this move will enhance the long-term accessibility of vaccines on the continent.

"This is a critical step forward in strengthening sustainable access to a vaccine in the fight against this tragic, worldwide pandemic," said Makhoana.

Covid-19 has lowered South Africa's life expectancy, according to Stats SA

Briefly News recently reported that a Stats SA report has uncovered that the Covid-19 pandemic has caused the life expectancy among South Africans to decline since the country recorded the first initial case of the virus in March 2020.

Read also

Joburg ANC promises 150 000 jobs in 1st week: "Another empty election promise"

The report stated that fatalities during the first and second waves caused an increase in the Crude Death Rate (CDR) which indicates the number of deaths per 1 000 people in a year. The CDR rate rose from 8.8 per 1 000 people in 2020 to 11.6 per 1 000 people; signifying an increase of roughly 34%.

Stats SA stated that vaccination, following safety measures like social distancing and sanitising hands and surfaces, would likely push South Africa to its previous life expectancy levels. SowetanLIVE reported that the country has gone through two waves of infections and is currently fighting the highly transmissible Delta variant.

The report stated that although the life expectancy at birth indicator is a more 'important' indicator, the Covid-19 pandemic will not be brought forward as a projection of one person's lifespan but it should rather be used to bring to light the cumulative burden of the crisis compared to recent trends.

Enjoyed reading our story? Download BRIEFLY's news app on Google Play now and stay up-to-date with major South African news!

Source: Briefly News

Authors:
Lebogang Mashego avatar

Lebogang Mashego (Current Affairs HOD) Lebogang Mashego runs the Current Affairs desk. She joined the Briefly News team in 2021. She has 6 years of experience in the journalism field. Her journalism career started while studying at Rhodes University, where she worked for the Oppidan Press for 3 years. She worked as a lifestyle writer and editor at W24 and Opera News. She graduated with a BA degree majoring in Journalism and Media Studies in 2017. She's a recipient of the INMA Elevate Scholarship. Email: lebogang.mashego@briefly.co.za

Tags: